The importance of ARs in asthma was also highlighted by a recent report that the inhalation of a novel glucocorticoid receptor agonist GW870086X (structure not shown) protects against adenosine-induced bronchoconstriction in asthma (Leaker et al., 2015). This evidence concerns the gene NR3C1 and asthma.